AI Biologist - Cell Therapy Discovery
LatchBio is hiring an AI Biologist - Cell Therapy Discovery for a remote role open to applicants in United States. It pays $140k-$180k a year and Level rates it ; you can apply on LatchBio.
Level's read on this job
- On Level's scale, this role is Works on AI ●●●○: the daily work is on AI products, without building the model.
- The posting lists this role as remote.
- LatchBio mentions visa sponsorship in this posting.
- Tools and skills the posting cites include Claude, Cursor and Python.
- Level lists 33 other open roles at LatchBio.
AI in this role
Design cell therapy discovery benchmarks and datasets to evaluate the reasoning capabilities of AI agents.
Latch builds rigorous scientific benchmarks (benchmarks.bio) for AI agents across biology. We work with frontier labs and pharma to measure whether agents can handle real biological workflows: the messy, multi-layer reasoning that matters in the field.
We're seeking an AI Biologist to join our Cell Therapy Discovery team, pushing what AI can achieve in engineered cell design.
About the Role
You will be the scientific authority on ground truth, testing whether agents can reason like an expert cell therapy scientist. The data misleads constantly: killing is not persistence, a marker is not a phenotype, and an apparent potency difference is often just a difference in how much receptor is on the cell. Knowing what the evidence actually supports is the work. You will build the tasks and datasets behind our benchmarks across CAR, TCR, and other engineered cell formats, from antigen selection to candidate nomination.
Build the task
Write gold-standard answers with the rationale an experienced cell therapy scientist would defend.
Design scenarios across the discovery arc: antigen prioritization, receptor and construct design, phenotype, potency and killing, cytokine profiling, exhaustion and persistence, on-target off-tumor triage.
Curate datasets from real programs: multiparameter flow and spectral panels, luciferase, impedance, and imaging cytotoxicity across E:T ratios, cytokine multiplex, repeat-stimulation and serial-killing assays, inhibitory receptor panels, memory phenotype distributions, normal-tissue antigen expression.
Build analysis pipelines in Python where useful, with tolerances that hold across donors, runs, and readout platforms.
Set the hard calls
Catch the artifact. A construct that looks weak because its surface expression is 20 percent rather than 90 percent. An E:T at saturation that erases a real potency difference visible only at lower ratios. A viability readout depressed because dead effectors overlay the targets at high E:T. Activation-induced cell death confounding a long co-culture. Lysis not normalized to the matched untransduced control at the same E:T. Donor variation read as a construct effect. Spillover error in a dim inhibitory-receptor channel.
Separate activation from exhaustion. PD-1, CD69, and CD25 rise transiently on recently activated effectors and prove nothing alone. Stable exhaustion needs sustained or repeated stimulation, multiple co-expressed inhibitory receptors, and functional loss. Test whether agents know which timepoint and evidence the claim requires.
Recognize tonic signaling. Antigen-independent activation from scFv instability and self-aggregation, or from hinge, transmembrane, and costimulatory domain choice, drives early differentiation and exhaustion with no antigen present. Higher affinity can raise antigen-specific and tonic signaling together. Test whether agents reach for the construct explanation instead of calling it biology.
Adjudicate conflicts. Strong short-term killing against poor persistence. Low cytokine output as a design choice or a failing product. Then name the experiment that settles it.
Weigh the tradeoffs. Potency versus exhaustion, cytokine output versus toxicity risk, affinity versus on-target off-tumor selectivity, and when an expansion gain costs a memory phenotype.
Judge the agent
Interrogate reasoning step by step, and challenge conclusions that would not survive a project review.
Pinpoint where agents go wrong: why the step fails, what an expert would do, what evidence would change the call.
Score confidence, rewarding explicit uncertainty over overconfident calls on ambiguous data.
Requirements
PhD in immunology, cell biology, bioengineering, or a related field. An MS with equivalent hands-on program experience also qualifies.
2 to 6 years hands-on in cell therapy at a biotech or pharma, with your own analysis work in the last two years.
You have personally generated or analyzed data that decided which target or construct advanced, and you can name the threshold and the call.
Direct experience with at least one of: CAR or TCR construct design, multiparameter flow panel design and analysis, cytotoxicity and co-culture assays, cytokine profiling, or exhaustion and persistence characterization.
Deep in one of those, fluent across the others.
Strong experimental design, quantitative analysis, and statistics.
AI-ready from day one: daily use of Claude, Cursor, or similar, with the judgment to spot where model reasoning is technically correct but scientifically unsound, and the confidence to overrule it.
Bonus: Python or R for your own analyses. Allogeneic or gene-edited cell therapy, NK or Treg formats, or in vivo CAR.
Compensation
$140K–$180K OTE (on-target earnings), with no ceiling.
Your pay is your OTE times your weekly quota attainment. Hit quota, earn your OTE; double it, earn double. Example: $150K OTE at double quota = $300K.
Your first 4 weeks (ramp) are paid at full OTE while you learn our workflows.
You’re paid full OTE whenever quota can’t fairly apply: when a new project is starting, the platform goes down, or we pull you onto a special project.
Benefits & Employment
In the US: full-time W-2
Guaranteed floor (“base salary”) set by your state, paid on the 15th and last day of every month
Health, dental, vision: 100% covered for you, 50% for dependents
401(k) (no match)
PTO: 15 days to start, more as you’re promoted
Outside the US: contractor
Paid on performance. We want our team to have stability, so we pay 60% of your monthly OTE up front as an advance, balanced against your earnings in later paychecks.
US benefits don’t apply.
Growth
Two tracks, based on output.
Individual contributor: six levels, so up to five promotions, with OTE rising at each one.
Management: after your first promotion, you can move into managing a pod or keep growing on the IC track.
Location & Work Authorization
Location: remote or onsite at our Mission Bay office in San Francisco. Onsite is preferred: working side by side is how we share knowledge and keep our work rigorous. We have a global team, and remote teammates regularly visit the office.
Work authorization: we sponsor H-1B (new and transfers), O-1, and TN, and support STEM OPT.
Culture @ Latch
We practice radical transparency: you’ll know how the company is doing, what’s working, and what isn’t. It’s always us against the problem, never each other. We’re opinionated but respectful of each other’s time, and we think through possible solutions before bringing a problem to anyone.
We use AI constantly, so we reward original expert judgment, not AI output passed off as your own. You’ll start on the bench that fits your expertise and can move across teams as you build a track record.
Outside of work: company outings most months, team off-sites, and a community that does cycling, soccer, figure skating, boxing, running, martial arts, music, books, and game nights.
Interview Process
Apply. If your profile matches, we’ll send you a take-home project.
Take-home project (HackerRank). We review it as soon as it arrives.
Technical interview with a Member of Technical Staff (pod lead).
Culture interview with our C-suite.
Offer.
Background check, once you accept.
How we rate this
AI Biologist - Cell Therapy Discovery at LatchBio rates 75 out of 100 for how much of the daily work is AI. That makes it Works on AI (AI Level 3 of 4). The level is about AI in the job, not seniority.
Works on AI. The daily work is on AI products, without building the model.
- ●●●● Builds AI80 to 100
- ●●●○ Works on AI60 to 79
- ●●○○ Uses AI40 to 59
- ●○○○ Little AI0 to 39
Levels come from how often the tools, models and workflows of the role are named in the posting itself. Read the description and count the AI tools, models and workflows it names.
Prepare for this job
Built from this posting and from similar jobs on Level.
Skills and AI tools this role asks for
Questions you could be asked
- How do you decide when an AI agent can act on its own versus asking for approval first?
- Tell me about a project where cell therapy was part of your work. What did you do?
- Tell me about a project where immunology was part of your work. What did you do?
- Tell me about a project where bioinformatics was part of your work. What did you do?
- Tell me about a project where computational biology was part of your work. What did you do?
Adapt your resume
- List these exact terms on your resume: AI agents, Cell Therapy, Immunology, Bioinformatics, and Computational Biology. An applicant tracking system matches the wording, not the idea.
- Attach one line of real, concrete experience to at least one of them. A tool named with nothing behind it rarely survives a human read.
- Show where AI is part of your daily process, not a one-off project. This role expects it to be a running habit.
Get your CV reviewed before you apply
Send your CV and the role you want next. Your review arrives by email within 3 days.
Get new remote AI jobs (Works on AI ●●●○ or higher) by email
One email a week, each job rated for how much AI is in the work. No recruiter spam, unsubscribe in one click.
Free.
Similar roles
Other roles that work on AI, at other companies.
What kind of AI work fits you?
Answer 12 practical questions in about three minutes. Get a simple profile, the work it points to, and live roles to explore next.
Find my next step